Rasul Reazur's most recent trade in Baxter International Inc. was a trade of 87,417 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Baxter International | Reazur Rasul | EVP,Group Pres,Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 87,417 | 87,417 | - | - | Stock Option (Right to Buy) | |
| Baxter International | Reazur Rasul | EVP,Group Pres,Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 26,220 | 124,614 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Baxter International | Reazur Rasul | EVP,Group Pres,Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.44 per share. | 06 Mar 2025 | 9,341 | 98,394 (0%) | 0% | 35.4 | 331,045 | Common Stock, $1 par value |
| Baxter International | Reazur Rasul | EVP,Group Pres,Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.86 per share. | 03 Mar 2025 | 1,987 | 107,735 (0%) | 0% | 34.9 | 69,267 | Common Stock, $1 par value |
| Baxter International | Reazur Rasul | EVP,Group Pres,Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.55 per share. | 02 Dec 2024 | 2,032 | 109,116 (0%) | 0% | 33.6 | 68,174 | Common Stock, $1 par value |
| Baxter International | Reazur Rasul | EVP,Group Pres, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 83,353 | 109,187 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Baxter International | Reazur Rasul | EVP, Group Pres, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.50 per share. | 04 Mar 2024 | 522 | 25,834 (0%) | 0% | 42.5 | 22,185 | Common Stock, $1 par value |
| Baxter International | Reazur Rasul | EVP, Group Pres, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.01 per share. | 01 Mar 2024 | 1,538 | 26,357 (0%) | 0% | 41.0 | 63,073 | Common Stock, $1 par value |
| Baxter International | Rasul Reazur | EVP, Group Pres, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 716 | 28,143 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Baxter International | Reazur Rasul | EVP, Group Pres, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.31 per share. | 12 Feb 2024 | 248 | 27,895 (0%) | 0% | 40.3 | 9,997 | Common Stock, $1 par value |